Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

AmCyte

1991 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of biotherapy treatment for diabetes. The company is the developer of a therapy utilizing encapsulated islet replacement and pancreatic adult stem cells, which secrete insulin into the blood and do not require long-term immune suppression to operate within the body.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 2825 Santa Monica Boulevard
  • Suite 200
  • Santa Monica, CA 90404
  • United States

AmCyte Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore AmCyte‘s full profile, request access.

Request full access to PitchBook

AmCyte Executive Team (1)

Name Title Board
Seat
Contact
Info
Terrance Shiong Chief Executive Officer